Pfizer lifts full-year outlook, names Cecile Guegan CFO
CNBC · RSS · · AI-summarised by FinFlash
Pfizer raised its full-year outlook, citing growth from its newer products. The company also named Cecile Guegan as chief financial officer; she stepped into the role this month after holding various leadership positions at Pfizer over the last 20 years. The guidance increase points to improving revenue momentum, a signal investors will weigh against the drugmaker's pipeline and cost outlook.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.